INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 36 filers reported holding INMUNE BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,269 | -25.4% | 4,471 | 0.0% | 0.00% | – |
| Q2 2023 | $40,597 | +33.2% | 4,471 | -5.2% | 0.00% | – |
| Q1 2023 | $30,472 | +156.9% | 4,717 | +152.1% | 0.00% | – |
| Q4 2022 | $11,862 | -1.2% | 1,871 | +0.7% | 0.00% | – |
| Q3 2022 | $12,000 | -25.0% | 1,858 | 0.0% | 0.00% | – |
| Q2 2022 | $16,000 | -46.7% | 1,858 | -47.8% | 0.00% | – |
| Q1 2022 | $30,000 | -21.1% | 3,558 | -5.6% | 0.00% | – |
| Q4 2021 | $38,000 | +8.6% | 3,769 | +109.5% | 0.00% | – |
| Q3 2021 | $35,000 | +16.7% | 1,799 | +5.8% | 0.00% | – |
| Q2 2021 | $30,000 | +50.0% | 1,700 | 0.0% | 0.00% | – |
| Q1 2021 | $20,000 | -31.0% | 1,700 | 0.0% | 0.00% | – |
| Q4 2020 | $29,000 | +3.6% | 1,700 | -37.0% | 0.00% | – |
| Q3 2020 | $28,000 | +211.1% | 2,700 | +57.6% | 0.00% | – |
| Q2 2020 | $9,000 | +50.0% | 1,713 | +0.8% | 0.00% | – |
| Q1 2020 | $6,000 | -40.0% | 1,700 | -0.2% | 0.00% | – |
| Q4 2019 | $10,000 | 0.0% | 1,703 | +0.2% | 0.00% | – |
| Q3 2019 | $10,000 | +25.0% | 1,700 | +112.0% | 0.00% | – |
| Q2 2019 | $8,000 | – | 802 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Westside Investment Management, Inc. | 37,105 | $239,703 | 0.07% |
| QUADRANT CAPITAL GROUP LLC | 60,000 | $387,600 | 0.04% |
| Janney Montgomery Scott LLC | 239,448 | $1,547 | 0.01% |
| Financial Advocates Investment Management | 11,500 | $74,290 | 0.01% |
| MAI Capital Management | 19,643 | $126,894 | 0.00% |
| VALLEY NATIONAL ADVISERS INC | 1,000 | $8 | 0.00% |
| NORTHERN TRUST CORP | 20,297 | $131,119 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 9,036 | $58,373 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 143,657 | $928,024 | 0.00% |